
<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/joey/Project/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<encodingDesc>
			<appInfo>
				<application version="0.4.2-SNAPSHOT" ident="GROBID" when="2017-08-10T23:32+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Data and text mining drexplorer: A tool to explore dose–response relationships and drug–drug interactions</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName>
								<forename type="first">Pan</forename>
								<surname>Tong</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Departments of Bioinformatics and Computational Biology</orgName>
								<address>
									<postCode>77030</postCode>
									<settlement>Houston</settlement>
									<region>TX</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Kevin</forename>
								<forename type="middle">R</forename>
								<surname>Coombes</surname>
							</persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Biomedical Informatics</orgName>
								<orgName type="institution">The Ohio State University</orgName>
								<address>
									<postCode>43210</postCode>
									<settlement>Columbus</settlement>
									<region>OH</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Faye</forename>
								<forename type="middle">M</forename>
								<surname>Johnson</surname>
							</persName>
							<affiliation key="aff2">
								<orgName type="department">Thoracic and Head and Neck Medical Oncology</orgName>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Lauren</forename>
								<forename type="middle">A</forename>
								<surname>Byers</surname>
							</persName>
							<affiliation key="aff2">
								<orgName type="department">Thoracic and Head and Neck Medical Oncology</orgName>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Lixia</forename>
								<surname>Diao</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Departments of Bioinformatics and Computational Biology</orgName>
								<address>
									<postCode>77030</postCode>
									<settlement>Houston</settlement>
									<region>TX</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Diane</forename>
								<forename type="middle">D</forename>
								<surname>Liu</surname>
							</persName>
							<affiliation key="aff3">
								<orgName type="department">Biostatistics</orgName>
								<orgName type="institution">The University of Texas MD Anderson Cancer Center</orgName>
								<address>
									<postCode>77030</postCode>
									<settlement>Houston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">J</forename>
								<forename type="middle">Jack</forename>
								<surname>Lee</surname>
							</persName>
							<affiliation key="aff3">
								<orgName type="department">Biostatistics</orgName>
								<orgName type="institution">The University of Texas MD Anderson Cancer Center</orgName>
								<address>
									<postCode>77030</postCode>
									<settlement>Houston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">John</forename>
								<forename type="middle">V</forename>
								<surname>Heymach</surname>
							</persName>
							<affiliation key="aff2">
								<orgName type="department">Thoracic and Head and Neck Medical Oncology</orgName>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Jing</forename>
								<surname>Wang</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Departments of Bioinformatics and Computational Biology</orgName>
								<address>
									<postCode>77030</postCode>
									<settlement>Houston</settlement>
									<region>TX</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Data and text mining drexplorer: A tool to explore dose–response relationships and drug–drug interactions</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="DOI">10.1093/bioinformatics/btv028</idno>
					<note type="submission">Received on October 3, 2014; revised on December 11, 2014; accepted on January 11, 2015</note>
					<note>*To whom correspondence should be addressed. Associate editor: Jonathan Wren Contact: jingwang@mdanderson.org Supplementary information: Supplementary data are available at Bioinformatics online.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract>
				<p>Motivation: Nonlinear dose–response models are primary tools for estimating the potency [e.g. half-maximum inhibitory concentration (IC) known as IC50] of anti-cancer drugs. We present drexplorer software, which enables biologists to evaluate replicate reproducibility, detect outlier data points, fit different models, select the best model, estimate IC values at different percentiles and assess drug–drug interactions. drexplorer serves as a computation engine within the R environment and a graphical interface for users who do not have programming backgrounds. Availability and implementation: The drexplorer R package is freely available from GitHub at https://github.com/nickytong/drexplorer. A graphical user interface is shipped with the package.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1">Introduction</head><p>Understanding the dose–response relationship of therapeutic compounds is a major focus of clinical oncology. Large-scale drug screening in cancer cell lines has demonstrated that different genomic characteristics (mutations) confer distinct drug sensitivity, supporting patient stratification into treatment regimens on the basis of genomic markers (<ref type="bibr" target="#b0">Barretina et al., 2012;</ref><ref type="bibr" target="#b9">Yang et al., 2013</ref>). Cell lines resistant to single-drug treatment may respond to synergistic drug combinations (<ref type="bibr" target="#b5">Lehár, et al., 2009</ref>). As cell viability assays become widely used, it is important to provide easily accessible tools to analyze drug profiling data. We developed drexplorer software in the R environment (R Core<ref type="bibr" target="#b7">Team, 2014</ref>) to encompass several aspects of dose–response analysis: assess reproducibility of replicated experiments, detect outlier data points, fit different models, identify the best model, estimate inhibitory concentration (IC) values and evaluate drug–drug interactions.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">Algorithms</head><p>A typical drug screening experiment exposes cells to a range of concentrations (doses) of a drug and quantifies cell viability (response). To account for experimental variations, multiple measurements are obtained for each dose. We denote the jth repeat of the ith dose by x ij and the corresponding response by y ij. For anti-cancer drug screening, response y ij is further scaled by the mean response of the controls (i.e. under x ij ¼ 0) and is called relative viability.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">Outlier detection</head><p>Outlier values in response y ij will affect dose–response curve fitting and IC estimation. We implement the Newman test (<ref type="bibr" target="#b6">Newman, 1939</ref>) to detect outliers, defining the test statistic as q ¼ w=s, where w is the maximum difference among the response vector ðy i1 ;. .. ; y imi Þ at the ith dose and s is the standard deviation of the response in untreated controls. Once calculated, the test statistic can be comparedwith the threshold value from the null distribution under the specified type I error (a ¼ 0:01 or 0:05). We apply this test to identify outlier data points at each dose separately.<ref type="figure" target="#fig_1">Figure 1a</ref>shows outlier detection using the ryegrass data (<ref type="bibr" target="#b8">Ritz and Streibig, 2005</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">Assessing reproducibility</head><p>When replicate experiments have been performed, it is necessary to assess the quality of the reproducibility. We use the concordance correlation coefficient (CCC) to capture both the location shift and the scale shift between replicates (<ref type="bibr" target="#b2">Lawrence and Lin, 1989</ref>). CCC ranges between À1 and 1, where CCC ¼ 1 means perfect agreement.<ref type="figure" target="#fig_1">Figure 1c</ref>illustrates the reproducibility assessment for two technical replicates run on different dates.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">The dose–response model</head><p>The dose–response model can be expressed as a nonlinear function:where h is the vector of unknown parameters, e ij is the measurement error for the response y ij , n is the total number of doses administered and m i is the number of repeats under the ith dose. The error term e ij is assumed to be identically independently distributed as Nð0; r 2 Þ. In the case of the sigmoid Emax model, f ðÁÞ has the following form:</p><formula>y ij ¼ E 0 þ E max x ij h ED50 h þ x ij h :</formula><p>Here, h ¼ ðE 0 ; E max ; ED50; hÞ is the vector of parameters to be estimated. The dose–response models in drexplorer include all the models in the drc (<ref type="bibr" target="#b8">Ritz and Streibig, 2005</ref>) and DoseFinding (<ref type="bibr" target="#b1">Bornkamp, et al., 2010</ref>) packages and can be easily used through a uniform interface. Parameters in the dose–response models can be estimated by minimizing the sum of the squared residuals (SSR):</p><formula>SSR ¼ X i X j fy ij À f ðx ij ; h Þg 2 :</formula><p>After fitting the model, we estimate the IC at percentile s by solving x in equation s ¼ f ðx; ^ h Þ; where ^ h is the vector of the fitted parameters. Different models can be fit, so we identify the best model as that with minimum residual standard error, calculated as SSR divided by degrees of freedom. Approaches for parametric dose–response models may use the Akaike information criterion or Bayesian information criterion.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4">The Interaction Index for Drug Combinations</head><p>The interaction index (IAI) is useful to quantify the degree of interaction in drug combinations. For a 2-drug combination, IAI can be defined as</p><formula>IAI ¼ d 1 D y;1 þ d 2 D y;2 &lt; 1; synergistic ¼ 1; additive &gt; 1; antagonistic : 8 &gt; &gt; &lt; &gt; &gt; :</formula><p>Here, D y,1 and D y,2 and are the doses needed to induce response y for drugs 1 and 2 when administered alone; d 1 and d 2 are the doses in the mixture that produce the same response y. We adopt the source code used by<ref type="bibr" target="#b4">Lee, et al. (2007)</ref>and Lee and Kong (2009) to estimate the IAI and 95% confidence interval (see<ref type="figure" target="#fig_1">Fig. 1b</ref>using UMSCC22B data;<ref type="bibr" target="#b3">Lee and Kong, 2009</ref>). Graphical user interfaces (GUIs) help users without advanced programming skills to analyze dose–response data (<ref type="figure" target="#fig_1">Fig. 1d</ref>and e).(c) Reproducibility assessment using concordance. Responses from two replicates are highly concordant showing good reproducibility. (d) GUI screenshot for dose–response estimation. (e) GUI screenshot for interaction index estimation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">Conclusion</head><p>Drexplorer is a versatile R package encompassing several aspects of dose–response and drug–drug interaction analysis. The GUI enables biologists without programming skills to analyze their data.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig.1.</head><figDesc>Fig. 1. Example of drexplorer output and GUI. (a) Outlier data at type I error ¼ 0.01 and 0.05 are, respectively, indicated by the green square and red triangle. Various dose–response curves are fitted; RSEs are indicated; title indicates model selected by RSE. (b) Interaction index estimated at different doses (blue line) and relative viability (black line); 95% confidence interval also shown. (c) Reproducibility assessment using concordance. Responses from two replicates are highly concordant showing good reproducibility. (d) GUI screenshot for dose–response estimation. (e) GUI screenshot for interaction index estimation.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0" validated="false"><figDesc>V C The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 1692 Bioinformatics, 31(10), 2015, 1692–1694 doi: 10.1093/bioinformatics/btv028 Advance Access Publication Date: 18 January 2015 Applications Note</figDesc><table></table></figure>

			<note place="foot">at :: on August 30, 2016 http://bioinformatics.oxfordjournals.org/ Downloaded from</note>

			<note place="foot">P.Tong et al. at :: on August 30, 2016 http://bioinformatics.oxfordjournals.org/ Downloaded from</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p>This project was partially supported by the NCI/NIH through the Lung SPORE (P50 CA070907) and Cancer Center Support Grant (CA016672), and by the Mary K. Chapman Foundation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict</head><p>of Interest: none declared.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct   xml:id="b0">
	<analytic>
		<title level="a" type="main">The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Barretina</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">483</biblScope>
			<biblScope unit="page" from="603" to="607" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b1">
	<monogr>
		<title level="m" type="main">DoseFinding: planning and analyzing dose finding experiments, R package version 0.4-1</title>
		<author>
			<persName>
				<forename type="first">B</forename>
				<surname>Bornkamp</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2010" />
		</imprint>
	</monogr>
	<note>packages/DoseFinding/DoseFinding.pdf</note>
</biblStruct>

<biblStruct   xml:id="b2">
	<analytic>
		<title level="a" type="main">A concordance correlation coefficient to evaluate reproducibility</title>
		<author>
			<persName>
				<forename type="first">I</forename>
				<surname>Lawrence</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">K</forename>
				<surname>Lin</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biometrics</title>
		<imprint>
			<biblScope unit="page" from="255" to="268" />
			<date type="published" when="1989" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b3">
	<analytic>
		<title level="a" type="main">Confidence intervals of interaction index for assessing multiple drug interaction</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">J</forename>
				<surname>Lee</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Kong</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stat. Biopharm. Res</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="4" to="17" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b4">
	<analytic>
		<title level="a" type="main">Interaction index and different methods for determining drug interaction in combination therapy</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">J</forename>
				<surname>Lee</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biopharm. Stat</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="461" to="480" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b5">
	<analytic>
		<title level="a" type="main">Synergistic drug combinations tend to improve therapeutically relevant selectivity</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Lehár</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Biotechnol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="659" to="666" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b6">
	<analytic>
		<title level="a" type="main">The distribution of range in samples from a normal population, expressed in terms of an independent estimate of standard deviation</title>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Newman</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biometrika</title>
		<imprint>
			<biblScope unit="page" from="31" to="51" />
			<date type="published" when="1939" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b7">
	<monogr>
		<title level="m" type="main">R: A Language and Environment for Statistical Computing. The R Foundation for Statistical Computing</title>
		<author>
			<persName>
				<forename type="first">R</forename>
				<surname>Core Team</surname>
			</persName>
		</author>
		<imprint>
			<date type="published" when="2014" />
			<pubPlace>Vienna, Austria</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b8">
	<analytic>
		<title level="a" type="main">Bioassay analysis using R</title>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Ritz</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">C</forename>
				<surname>Streibig</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Stat. Softw</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1" to="22" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b9">
	<analytic>
		<title level="a" type="main">Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells</title>
		<author>
			<persName>
				<forename type="first">W</forename>
				<surname>Yang</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="955" to="961" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>